SENSIMED Triggerfish: Clinical Trials

2 trials of SENSIMED Triggerfish, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Terminated 2

Follow SENSIMED Triggerfish: new trials by email Literature Review of SENSIMED Triggerfish trials Research Report on SENSIMED Triggerfish

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection
Intraocular anti-VEGF injection, SENSIMED Triggerfish - Neovascular Age Related Macular Degeneration (AMD), Open Angle Glaucoma
Phase 4TerminatedSensimed AG42013-10-012015-11-17
Use of an Ocular Telemetry Sensor in Tafluprost Treated Patients
SENSIMED Triggerfish - Glaucoma
Phase 4TerminatedSensimed AG152010-09-012012-08-28

Conditions studied

Glaucoma (1)  ·  Glaucoma, Open-Angle (1)

Sponsors

Sensimed AG (2)

Countries

Spain (1)  ·  Switzerland (1)

Top investigators

Roberto Gallego Pinazo (1)